1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
Financial Results, Press Release
Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Other Events
Director Elections and Executive Compensation Approved at Annual Meeting
To Acquire Vega Therapeutics, a Wholly Owned Subsidiary, Expanding its Hematology Portfolio into Bleeding Disorders
Annual Report to Security Holders
Results of Operations and Financial Condition
Director Resignation - Susanne Schaffert Steps Down from Board
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
SC TO-I
Tender Offer Statement by Issuer
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Issuer
Submission Upload
Correspondence